Skip to main content
Seaport Therapeutics, Inc. (SPTX)
Seaport Therapeutics will go public soon. The estimated IPO date is May 1, 2026.
IPO Price Range
$16.00 - $18.00
Shares Offered
11,800,000
Deal Size
$200.60M

Seaport Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Ending
 Current Dec '25 Dec '24
Market Capitalization
861--
Enterprise Value
650--
Debt / Equity Ratio
-0.05-0.05-0.20
Debt / EBITDA Ratio
-0.06-0.06-0.10
Debt / FCF Ratio
-0.06-0.06-0.17
Net Debt / Equity Ratio
2.282.2812.24
Net Debt / EBITDA Ratio
2.412.415.83
Net Debt / FCF Ratio
2.692.6910.22
Quick Ratio
16.9016.9027.72
Return on Equity (ROE)
80.91%80.91%188.66%
Return on Assets (ROA)
-30.07%-30.07%-14.85%
Return on Capital Employed (ROCE)
-36.20%-36.20%-17.21%
Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).